The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Immunohematology-Global Market Insights and Sales Trends 2024
Synopsis
Immunohematology assists in the screening of blood antigens, Rh factor, plasma, and white blood cell components in the donor blood. It is commonly known as blood banking, which deals with preparation of blood components for transfusion. It aids in reduction of transfusion-related fatalities, such as HIV and thalassemia.
The global Immunohematology market size is expected to reach US$ 1797.1 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Immunohematology in various end use industries. The expanding demands from the Blood-Related Diseases, HIV and Hepatitis,, are propelling Immunohematology market. Immunohematology Analyzers and Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunohematology Reagent segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunohematology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunohematology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunohematology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunohematology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunohematology covered in this report include Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostic, BD, Beckman Coulter, DIAGAST, Hemo bioscience and Institut de Biotechnologies Jacques Boy, etc.
The global Immunohematology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
Grifols
Immucor
Ortho Clinical Diagnostic
BD
Beckman Coulter
DIAGAST
Hemo bioscience
Institut de Biotechnologies Jacques Boy
MTC INVITRO
Seqirus
Tulip Group
Global Immunohematology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunohematology market, Segment by Type:
Immunohematology Analyzers and Systems
Immunohematology Reagent
Global Immunohematology market, by Application
Blood-Related Diseases
HIV
Hepatitis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunohematology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Immunohematology assists in the screening of blood antigens, Rh factor, plasma, and white blood cell components in the donor blood. It is commonly known as blood banking, which deals with preparation of blood components for transfusion. It aids in reduction of transfusion-related fatalities, such as HIV and thalassemia.
The global Immunohematology market size is expected to reach US$ 1797.1 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Immunohematology in various end use industries. The expanding demands from the Blood-Related Diseases, HIV and Hepatitis,, are propelling Immunohematology market. Immunohematology Analyzers and Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immunohematology Reagent segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Immunohematology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Immunohematology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Immunohematology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Immunohematology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Immunohematology covered in this report include Bio-Rad Laboratories, Grifols, Immucor, Ortho Clinical Diagnostic, BD, Beckman Coulter, DIAGAST, Hemo bioscience and Institut de Biotechnologies Jacques Boy, etc.
The global Immunohematology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories
Grifols
Immucor
Ortho Clinical Diagnostic
BD
Beckman Coulter
DIAGAST
Hemo bioscience
Institut de Biotechnologies Jacques Boy
MTC INVITRO
Seqirus
Tulip Group
Global Immunohematology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Immunohematology market, Segment by Type:
Immunohematology Analyzers and Systems
Immunohematology Reagent
Global Immunohematology market, by Application
Blood-Related Diseases
HIV
Hepatitis
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Immunohematology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Immunohematology
1.1 Immunohematology Market Overview
1.1.1 Immunohematology Product Scope
1.1.2 Immunohematology Market Status and Outlook
1.2 Global Immunohematology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Immunohematology Market Size by Region (2018-2029)
1.4 Global Immunohematology Historic Market Size by Region (2018-2023)
1.5 Global Immunohematology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Immunohematology Market Size (2018-2029)
1.6.1 North America Immunohematology Market Size (2018-2029)
1.6.2 Europe Immunohematology Market Size (2018-2029)
1.6.3 Asia-Pacific Immunohematology Market Size (2018-2029)
1.6.4 Latin America Immunohematology Market Size (2018-2029)
1.6.5 Middle East & Africa Immunohematology Market Size (2018-2029)
2 Immunohematology Market by Type
2.1 Introduction
2.1.1 Immunohematology Analyzers and Systems
2.1.2 Immunohematology Reagent
2.2 Global Immunohematology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Immunohematology Historic Market Size by Type (2018-2023)
2.2.2 Global Immunohematology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Immunohematology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Immunohematology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Immunohematology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Immunohematology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Immunohematology Revenue Breakdown by Type (2018-2029)
3 Immunohematology Market Overview by Application
3.1 Introduction
3.1.1 Blood-Related Diseases
3.1.2 HIV
3.1.3 Hepatitis
3.2 Global Immunohematology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Immunohematology Historic Market Size by Application (2018-2023)
3.2.2 Global Immunohematology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Immunohematology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Immunohematology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Immunohematology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Immunohematology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Immunohematology Revenue Breakdown by Application (2018-2029)
4 Immunohematology Competition Analysis by Players
4.1 Global Immunohematology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunohematology as of 2022)
4.3 Date of Key Players Enter into Immunohematology Market
4.4 Global Top Players Immunohematology Headquarters and Area Served
4.5 Key Players Immunohematology Product Solution and Service
4.6 Competitive Status
4.6.1 Immunohematology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad Laboratories
5.1.1 Bio-Rad Laboratories Profile
5.1.2 Bio-Rad Laboratories Main Business
5.1.3 Bio-Rad Laboratories Immunohematology Products, Services and Solutions
5.1.4 Bio-Rad Laboratories Immunohematology Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Laboratories Recent Developments
5.2 Grifols
5.2.1 Grifols Profile
5.2.2 Grifols Main Business
5.2.3 Grifols Immunohematology Products, Services and Solutions
5.2.4 Grifols Immunohematology Revenue (US$ Million) & (2018-2023)
5.2.5 Grifols Recent Developments
5.3 Immucor
5.3.1 Immucor Profile
5.3.2 Immucor Main Business
5.3.3 Immucor Immunohematology Products, Services and Solutions
5.3.4 Immucor Immunohematology Revenue (US$ Million) & (2018-2023)
5.3.5 Ortho Clinical Diagnostic Recent Developments
5.4 Ortho Clinical Diagnostic
5.4.1 Ortho Clinical Diagnostic Profile
5.4.2 Ortho Clinical Diagnostic Main Business
5.4.3 Ortho Clinical Diagnostic Immunohematology Products, Services and Solutions
5.4.4 Ortho Clinical Diagnostic Immunohematology Revenue (US$ Million) & (2018-2023)
5.4.5 Ortho Clinical Diagnostic Recent Developments
5.5 BD
5.5.1 BD Profile
5.5.2 BD Main Business
5.5.3 BD Immunohematology Products, Services and Solutions
5.5.4 BD Immunohematology Revenue (US$ Million) & (2018-2023)
5.5.5 BD Recent Developments
5.6 Beckman Coulter
5.6.1 Beckman Coulter Profile
5.6.2 Beckman Coulter Main Business
5.6.3 Beckman Coulter Immunohematology Products, Services and Solutions
5.6.4 Beckman Coulter Immunohematology Revenue (US$ Million) & (2018-2023)
5.6.5 Beckman Coulter Recent Developments
5.7 DIAGAST
5.7.1 DIAGAST Profile
5.7.2 DIAGAST Main Business
5.7.3 DIAGAST Immunohematology Products, Services and Solutions
5.7.4 DIAGAST Immunohematology Revenue (US$ Million) & (2018-2023)
5.7.5 DIAGAST Recent Developments
5.8 Hemo bioscience
5.8.1 Hemo bioscience Profile
5.8.2 Hemo bioscience Main Business
5.8.3 Hemo bioscience Immunohematology Products, Services and Solutions
5.8.4 Hemo bioscience Immunohematology Revenue (US$ Million) & (2018-2023)
5.8.5 Hemo bioscience Recent Developments
5.9 Institut de Biotechnologies Jacques Boy
5.9.1 Institut de Biotechnologies Jacques Boy Profile
5.9.2 Institut de Biotechnologies Jacques Boy Main Business
5.9.3 Institut de Biotechnologies Jacques Boy Immunohematology Products, Services and Solutions
5.9.4 Institut de Biotechnologies Jacques Boy Immunohematology Revenue (US$ Million) & (2018-2023)
5.9.5 Institut de Biotechnologies Jacques Boy Recent Developments
5.10 MTC INVITRO
5.10.1 MTC INVITRO Profile
5.10.2 MTC INVITRO Main Business
5.10.3 MTC INVITRO Immunohematology Products, Services and Solutions
5.10.4 MTC INVITRO Immunohematology Revenue (US$ Million) & (2018-2023)
5.10.5 MTC INVITRO Recent Developments
5.11 Seqirus
5.11.1 Seqirus Profile
5.11.2 Seqirus Main Business
5.11.3 Seqirus Immunohematology Products, Services and Solutions
5.11.4 Seqirus Immunohematology Revenue (US$ Million) & (2018-2023)
5.11.5 Seqirus Recent Developments
5.12 Tulip Group
5.12.1 Tulip Group Profile
5.12.2 Tulip Group Main Business
5.12.3 Tulip Group Immunohematology Products, Services and Solutions
5.12.4 Tulip Group Immunohematology Revenue (US$ Million) & (2018-2023)
5.12.5 Tulip Group Recent Developments
6 North America
6.1 North America Immunohematology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Immunohematology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Immunohematology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Immunohematology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Immunohematology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Immunohematology Market Dynamics
11.1 Immunohematology Industry Trends
11.2 Immunohematology Market Drivers
11.3 Immunohematology Market Challenges
11.4 Immunohematology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
